ImageneBio, Inc. (IMA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $39.86M
Last updated: Nov 17, 2026 at 4:10 PM ET
ImageneBio, Inc. (IMA) Statistics
ImageneBio (IMA) has a market cap of $39.86M. It kept -5700.13% of revenue as net income over the last 12 months. Its share count is up 94.64% from a year earlier.
Total Valuation
| Market Cap | $39.86M |
|---|---|
| Latest price (Nov 17, 2026) | $3.90 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 83.5x and 0.5x. Its year-end P/S ranged from 74.0x to 479.7x from 2021 to 2024.
| P/S Ratio | 83.5x |
|---|---|
| P/B Ratio | 0.5x |
Price Statistics
The stock is down 52.24% over 52 weeks and trades 9.93% below its 50-day average.
| Beta (1Y) | 0.64 |
|---|---|
| 52-Week Change | -52.24% |
| 1-Month Change | -2.50% |
| 3-Month Change | -31.46% |
| 6-Month Change | -25.71% |
| 5-Year Change | -96.82% |
| Total Return (1Y) | -52.24% |
| Total Return (3Y CAGR) | -43.47% |
| Total Return (5Y CAGR) | -54.21% |
| Return vs SPY (1Y) | -60.45% |
| Max Drawdown (1Y) | -58.44% |
| Max Drawdown (3Y) | -88.20% |
| Sharpe Ratio (1Y) | -1.12 |
| Correlation with SPY (1Y) | 0.15 |
| 50-Day Average | $4.33 |
| 200-Day Average | $5.44 |
| 52-Week Range | $3.13 to $7.89 |
| RSI (14 Days) | 47.4 |
| Average Volume (20 Days) | 15.04K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 16.17x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 16.17x |
|---|---|
| Quick Ratio | 16.17x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -35.59% and return on assets is -31.99% over the last 12 months.
| Return on Equity (ROE) | -35.59% |
|---|---|
| Return on Assets (ROA) | -31.99% |
| ROA (5Y Average) | -69.70% |
| ROIC (5Y Average) | -35.58% |
| Asset Turnover | 0.01x |
Scores
IMA has an Altman Z-Score of 0.07, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.07 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $800.00K over the last 12 months matched the 12 months before.
| Revenue | $800.00K |
|---|---|
| Revenue Growth (YoY) | 0.00% |
| Gross Profit | $800.00K |
| Operating Income | -$43.48M |
| Pretax Income | -$45.87M |
| Net Income | -$45.60M |
| Reported EPS (TTM) | -$3.11 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 89.90% of the $142.54M in total assets.
| Cash and Equivalents | $84.85M |
|---|---|
| Total Debt | $0 |
| Net Cash | $84.85M |
| Net Cash Per Share | $4.96 |
| Working Capital | $122.52M |
| Shareholder Equity | $128.14M |
| Book Value Per Share | $7.48 |
| Total Assets | $142.54M |
| Total Liabilities | $14.40M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$40.61M |
|---|---|
| FCF Per Share | -$3.57 |
| Depreciation and Amortization | $1.04M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -5435.63%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -5435.63% |
| Pretax Margin | -5734.25% |
| Net Margin | -5700.13% |
Growth
Revenue fell 62.86% a year over 3 years.
| Revenue Growth (3Y CAGR) | -62.86% |
|---|---|
| Revenue Growth (5Y CAGR) | -38.64% |
Dividends and Yields
IMA does not pay a dividend.
| Buyback Yield | 0.04% |
|---|---|
| Shareholder Yield | 0.04% |
Stock Splits
The last split was a 1-for-12 reverse split on Jul 28, 2025.
| Last Split Date | Jul 28, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Peer Position
Against 4 similar companies, IMA has the 3rd highest P/S.
P/S RatioPeer median 124.6x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -100.00%
| P/S Ratio | 83.5x vs 124.6x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | 0.00% vs -100.00% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IMA
What is IMA's market cap?
ImageneBio has a market cap of $39.86M.
How many shares of IMA are outstanding?
ImageneBio has 17.12M shares outstanding. The count is up 94.64% from a year earlier.
Does IMA pay a dividend?
No. ImageneBio does not pay a dividend.
How much debt does IMA have?
ImageneBio has $0 of total debt and $84.85M of cash and equivalents, a net cash position of $84.85M.
IMA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors